Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Sponsor
Technische Universität Dresden (Other)
Overall Status
Completed
CT.gov ID
NCT00180180
Collaborator
(none)
60
1
147
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
    Study Start Date :
    Jul 1, 2006
    Actual Primary Completion Date :
    Mar 1, 2017
    Actual Study Completion Date :
    Oct 1, 2018

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 70 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • histologically confirmed head-and-neck cancer not curable by surgery

      • Karnofsky > 70%

      • tumor volume and localisation allow curative radiotherapy

      • written consent

      Exclusion Criteria:
      • metastases

      • earlier radiation therapy of head and neck

      • pregnancy

      • secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri

      • psychiatric impairment

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Department of Nuclear Medicine Dresden Germany 01307

      Sponsors and Collaborators

      • Technische Universität Dresden

      Investigators

      • Principal Investigator: Joerg Kotzerke, MD, Department of Nuclear Medicine

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Jörg Kotzerke, Prof. Dr., Technische Universität Dresden
      ClinicalTrials.gov Identifier:
      NCT00180180
      Other Study ID Numbers:
      • HNO-FMISO-FU
      First Posted:
      Sep 16, 2005
      Last Update Posted:
      Mar 2, 2020
      Last Verified:
      Feb 1, 2020
      Keywords provided by Jörg Kotzerke, Prof. Dr., Technische Universität Dresden
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Mar 2, 2020